이스라엘 - 히브리어 - Ministry of Health

bioavenir ltd - lactulose 66.7 g / 100 ml - solution (oral) - lactulose - chronic constipation. acute and chronic hepatic encephalopathy.

이스라엘 - 히브리어 - Ministry of Health

bioavenir ltd - lactulose 66.7 g / 100 ml - solution (oral) - lactulose - chronic constipation. acute and chronic hepatic encephalopathy.

이스라엘 - 히브리어 - Ministry of Health

novo nordisk ltd - insulin aspart 100 u/ml - solution for injection - penfill - insulin aspart - treatment of patients with diabetes mellitus.

이스라엘 - 히브리어 - Ministry of Health

astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.

이스라엘 - 히브리어 - Ministry of Health

astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.

이스라엘 - 히브리어 - Ministry of Health

astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.

이스라엘 - 히브리어 - Ministry of Health

astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.

이스라엘 - 히브리어 - Ministry of Health

rafa laboratories ltd - potassium citrate 0.43 g / 5 ml; potassium gluconate 1.4 g / 5 ml - solution (oral) - combinations - prevention and treatment of hypokalemia.

이스라엘 - 히브리어 - Ministry of Health

kamada ltd - heparin as sodium 100 iu/ml - solution for injection - heparin - to maintain patency of an indwelling intravenous catheter designed for intermittent injection or blood sampling.

이스라엘 - 히브리어 - Ministry of Health

medic trim healthcare ltd - heparin sodium 5000 iu/ml - solution for injection - heparin - anticoagulant, treatment of arterial and venous thrombosis, prevention of thromo-embolic complications after surgery.